FDA
-
-
-
-
-
-
-
Recro Pharma Reports Third Quarter 2019 Financial Results
-
-
-
-
-
-
-
Recro Pharma Reports Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
Recro Pharma Reports First Quarter 2019 Financial Results
-
-
-
-
-
-
-
After-Hours Movers 04/03: (REPH) (TST) (CBLK) Higher; (NSPR) (AVEO) (SGMO) (more...)
-
-
-
-
-
-
-
Recro Pharma (REPH) PT Lowered to $9 at Oppenheimer Following IV Meloxicam CRL
-
-
-
-
-
-
-
Recro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting
-
-
-
-
-
-
-
Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

